Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis

被引:5
作者
Xu, Shi-Hao [1 ,2 ]
Wu, Fang [3 ]
Guo, Le-Hang [1 ]
Zhang, Wei-Bing [1 ]
Xu, Hui-Xiong [1 ]
机构
[1] Nanjing Med Univ, Shanghai Peoples Hosp 10, Dept Med Ultrasound, 301 Yanchang Middle Rd, Shanghai 200072, Peoples R China
[2] Wenzhou Med Univ, Dept Ultrasonog, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou 325000, Zhejiang, Peoples R China
关键词
Real-time tissue elastography; Chronic hepatitis B; Cirrhosis; Esophageal varices; Nomogram; Decision curve analysis; TIME TISSUE ELASTOGRAPHY; COUNT/SPLEEN DIAMETER RATIO; NONINVASIVE ASSESSMENT; GASTROESOPHAGEAL VARICES; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; PLATELET COUNT; KINGS SCORE; RISK; PREDICTION;
D O I
10.3748/wjg.v26.i45.7204
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Esophageal varices (EV) are the most fatal complication of chronic hepatitis B (CHB) related cirrhosis. The prognosis is poor, especially after the first upper gastrointestinal hemorrhage. AIM To construct nomograms to predict the risk and severity of EV in patients with CHB related cirrhosis. METHODS Between 2016 and 2018, the patients with CHB related cirrhosis were recruited and divided into a training or validation cohort at The First Affiliated Hospital of Wenzhou Medical University. Clinical and ultrasonic parameters that were closely related to EV risk and severity were screened out by univariate and multivariate logistic regression analyses, and integrated into two nomograms, respectively. Both nomograms were internally and externally validated by calibration, concordance index (C-index), receiver operating characteristic curve, and decision curve analyses (DCA). RESULTS A total of 307 patients with CHB related cirrhosis were recruited. The independent risk factors for EV included Child-Pugh class [odds ratio (OR) = 7.705, 95% confidence interval (CI) = 2.169-27.370, P = 0.002], platelet count (OR = 0.992, 95%CI = 0.984-1.000, P = 0.044), splenic portal index (SPI) (OR = 3.895, 95%CI = 1.630-9.308, P = 0.002), and liver fibrosis index (LFI) (OR = 3.603, 95%CI = 1.336-9.719, P = 0.011); those of EV severity included Child-Pugh class (OR = 5.436, 95%CI = 2.112-13.990, P < 0.001), mean portal vein velocity (OR = 1.479, 95%CI = 1.043-2.098, P = 0.028), portal vein diameter (OR = 1.397, 95%CI = 1.021-1.912, P = 0.037), SPI (OR = 1.463, 95%CI = 1.030-2.079, P = 0.034), and LFI (OR = 3.089, 95%CI = 1.442-6.617, P = 0.004). Two nomograms (predicting EV risk and severity, respectively) were well-calibrated and had a favorable discriminative ability, with C-indexes of 0.916 and 0.846 in the training cohort, respectively, higher than those of other predictive indexes, like LFI (C-indexes = 0.781 and 0.738), SPI (C-indexes = 0.805 and 0.714), ratio of platelet count to spleen diameter (PSR) (C-indexes = 0.822 and 0.726), King's score (C-indexes = 0.694 and 0.609), and Lok index (C-indexes = 0.788 and 0.700). The areas under the curves (AUCs) of the two nomograms were 0.916 and 0.846 in the training cohort, respectively, higher than those of LFI (AUCs = 0.781 and 0.738), SPI (AUCs = 0.805 and 0.714), PSR (AUCs = 0.822 and 0.726), King's score (AUCs = 0.694 and 0.609), and Lok index (AUCs = 0.788 and 0.700). Better net benefits were shown in the DCA. The results were validated in the validation cohort. CONCLUSION Nomograms incorporating clinical and ultrasonic variables are efficient in noninvasively predicting the risk and severity of EV.
引用
收藏
页码:7204 / 7221
页数:18
相关论文
共 50 条
  • [21] Liver Stiffness as a Predictor of Esophageal Varices Requiring Therapy in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis
    Pineda, Juan A.
    Recio, Eva
    Camacho, Angela
    Macias, Juan
    Almodovar, Carmen
    Gonzalez-Serrano, Mercedes
    Merino, Dolores
    Tellez, Francisco
    Jose Rios, Maria
    Rivero, Antonio
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (04) : 445 - 449
  • [22] Transient Elastography Identifies the Risk of Esophageal Varices and Bleeding in Patients With Hepatitis B Virus-Related Liver Cirrhosis
    Zhu, Qingjing
    Wang, Weijun
    Zhao, Jinfang
    AL-Asbahi, Afnan Ahmed Mohamed
    Huang, Ying
    Du, Fan
    Zhou, Jianning
    Song, Yuhu
    Xu, Keshu
    Ye, Jin
    Yang, Ling
    ULTRASOUND QUARTERLY, 2018, 34 (03) : 141 - 147
  • [23] Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B
    Wang, Jian
    Xia, Juan
    Yan, Xiaomin
    Yang, Yue
    Wei, Jie
    Xiong, Yali
    Wu, Weihua
    Liu, Yong
    Chen, Yuxin
    Jia, Bei
    Chen, Zhong
    Zhang, Zhaoping
    Ding, Weimao
    Huang, Rui
    Wu, Chao
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (06) : 602 - 609
  • [24] Nomogram based on spleen volume expansion rate predicts esophagogastric varices bleeding risk in patients with hepatitis B liver cirrhosis
    Li, Jianghong
    Li, Junjie
    Ji, Qian
    Wang, Zhenglu
    Wang, Honghai
    Zhang, Sai
    Fan, Shunli
    Wang, Hao
    Kong, Dejun
    Ren, Jiashu
    Zhou, Yunhui
    Yang, Ruining
    Zheng, Hong
    FRONTIERS IN SURGERY, 2022, 9
  • [25] The role of spleen stiffness using ARFI in predicting esophageal varices in patients with Hepatitis B and C virus-related cirrhosis
    Peagu, Razvan
    Sararu, Roxana
    Necula, Ana
    Moldoveanu, Alexandru
    Petrisor, Ana
    Fierbinteanu-Braticevici, Carmen
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2019, 57 (04) : 334 - 340
  • [26] Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis
    Hsieh, Yung-Yu
    Chen, Wei-Ming
    Chang, Kao-Chi
    Chang, Te-Sheng
    Hung, Chao-Hung
    Yang, Yao-Hsu
    Tung, Shui-Yi
    Wei, Kuo-Liang
    Shen, Chen-Heng
    Wu, Cheng-Shyong
    Ding, Yuan-Jie
    Hu, Jing-Hong
    Huang, Yu-Ting
    Lin, Meng-Hung
    Lu, Chung-Kuang
    Lin, Yi-Hsiung
    Lin, Ming-Shyan
    VIRUSES-BASEL, 2023, 15 (01):
  • [27] Apelin Association with Hepatic Fibrosis and Esophageal Varices in Patients with Chronic Hepatitis C Virus
    Soliman, Lamyaa Abdellatif
    Zayed, Rania A.
    Omran, Dalia
    Said, Fadwa
    Darweesh, Samar Kamal
    Ghaith, Doaa Mohamed
    Eletreby, Rasha
    Barakat, Mahmoud Salama
    Bendary, Mahmoud M.
    Zaky, Doaa Zakaria
    Amer, Eman
    Elmahgoub, Iman Rifaat
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 107 (01) : 190 - 197
  • [28] Progression to cirrhosis, hepatocellular carcinoma and liver- related mortality in chronic hepatitis B patients in Italy
    Ieluzzi, Donatella
    Covolo, Loredana
    Donato, Francesco
    Fattovich, Giovanna
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (05) : 427 - 432
  • [29] Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis
    Koga, Hiroyuki
    Ide, Tatsuya
    Oho, Kazuhiko
    Kuwahara, Reiichiro
    Hino, Teruko
    Ogata, Kei
    Hisamochi, Akiko
    Tanaka, Kazuo
    Kumashiro, Ryukichi
    Toyonaga, Atsushi
    Sata, Michio
    HEPATOLOGY RESEARCH, 2007, 37 (07) : 503 - 509
  • [30] Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis
    Elshazly, Helmy
    Zaghlah, Hasan
    Tharwa, El-Sayed
    Abuamer, Ahmed
    Nor-Eldin, Dina
    El Sheemy, Reem
    El Kassas, Mohamed
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)